TY  - CONF

T1  - The vascular-targeting agent, ZD6126, and the antiangiogenic agent, ZD6474, inhibit liver metastases via differential effects on metastatic vasculature.

JO  - CLINICAL CANCER RESEARCH

PY  - 2003/01/01

AU  - Varghese HJ

AU  - Mackenzie LT

AU  - Groom AC

AU  - Ellis CG

AU  - Ryan AJ

AU  - MacDonald IC

AU  - Chambers AF

ED  - 

VL  - 9

IS  - 16

SP  - 6141S

EP  - 6141S

Y2  - 2024/12/26

ER  -